Efficacy of Simultaneous Application of Subretinal Tissue Plasminogen Activator and Bevacizumab for Submacular Hemorrhages

OBJECTIVES: The aim of the study was to evaluate the patients who received simultaneous subretinal tissue plasminogen activator (tPA) and bevacizumab for submacular hemorrhages secondary to neovascular age-related macular degeneration. METHODS: This retrospective study included patients who underwen...

Descripción completa

Detalles Bibliográficos
Autores principales: Limon, Utku, Gezginaslan, Tugba Aydogan, Saygin, Isilay Ozsoy, Bozkurt, Erdinc, Kardes, Esra, Akcay, Betul Ilkay Sezgin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521123/
https://www.ncbi.nlm.nih.gov/pubmed/37766772
http://dx.doi.org/10.14744/bej.2023.34735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521123/
https://www.ncbi.nlm.nih.gov/pubmed/37766772
http://dx.doi.org/10.14744/bej.2023.34735

Ejemplares similares